Hospitalization

Treatment with neutralizing monoclonal antibodies in COVID-19 outpatients resulted in fewer hospital admissions and deaths vs. no antibody treatment, according to results published in CHEST.

People with HIV diagnosed with mpox were not at an increased risk for hospitalization unless they were immunosuppressed, according to findings presented at the International AIDS Society Conference on HIV Science.

Fewer patients with community-acquired pneumonia using corticosteroids vs. standard care needed mechanical ventilation, but mortality rates did not differ between both groups, according to study results published in CHEST.

Patients experienced differences in rates of ventilation, intubation, cardiac arrest and mortality after hospitalization for asthma based on race, according to a letter published in Annals of Allergy, Asthma & Immunology.

A study of more than 50 adults with a serious inflammatory syndrome linked to SARS-CoV-2 infection found that fewer than half were diagnosed with the condition while they were hospitalized.

Exposure to elevated levels of air pollutants before COVID-19 hospitalization increased length of hospital stay and risk for ICU admission, according to study results published in European Respiratory Journal.

A post-hospitalization home-delivered meal program was linked to lower 30-day mortality and rehospitalization, according to the results of research published in JAMA Health Forum.

Children of parents with alcohol-related liver disease had up to a more than fourfold increased risk for alcohol-related hospitalization, despite a low absolute risk for developing alcohol-related liver disease.

WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.

Patients with nonalcoholic fatty liver disease had a significantly greater risk for severe infection requiring hospitalization vs. the general population, with an absolute risk difference of more than 17%at 20 years after diagnosis.